- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02805062
Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy (MASCOT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Malignant pleural effusion is a common clinical problem with median survival of approximately 6 months. Efficient management of Malignant pleural effusion is therefore a major priority for patients, for whom failed procedures and the need for repeat hospital admissions limits their time at home with family and friends.
The management of Malignant pleural effusion involves either complete pleural fluid drainage followed by some form of pleurodesis or insertion of an indwelling pleural catheter. Apposition of the parietal and visceral pleural surfaces is a pre-requisite for successful pleurodesis. In patients with a non-expansile, or Trapped Lung, pleurodesis will be unsuccessful and an indwelling pleural catheter should be inserted instead. Accurate detection of Trapped Lung prior to insertion would avoid futile attempts at talc pleurodesis, re-intervention following failed pleurodesis and allow adequate time to plan for an indwelling pleural catheter insertion, including training of the patient's District Nurses. Clinical judgment is currently used to detect Trapped Lung. This involves review of available imaging and direct visualisation of the surface of the lung during local anaesthetic thoracoscopy. Unfortunately, recent data suggest this is frequently inaccurate, with 30% and 13% of cases of Trapped Lung correctly identified in recent local and national audit data respectively.
Pleural manometry allows direct and objective measurement of intra-pleural pressure during pleural fluid aspiration. Pleural pressure measurements can also be used to compute Pleural Elastance, defined as change in pleural pressure divided by change in pleural volume. Previous studies have shown that a rapid and sustained drop in intra-pleural pressure during fluid aspiration can predict Trapped Lung but these data have not been prospectively compared with current clinical practice.
The primary aim of this study is to determine whether the addition of digital pleural manometry to clinical judgment, prior to and during local anaesthetic thoracoscopy, results in a clinically meaningful improvement in Trapped Lung detection. Digital pleural manometry will be recorded using a Conformité Européene marked (CE-marked) device used within its existing clinical indication (developed in conjunction with our commercial partner Rocket Medical plc).
65 Subjects will have a single study visit, which will coincide with their planned clinical admission for local anaesthetic thoracoscopy. Subjects will exit the study after a follow-up clinic visit 3 months after the date of local anaesthetic thoracoscopy. A study-specific volumetric Magnetic Resonance Imaging scan of the pleural cavity will be performed as per pre-defined imaging protocols.
The study will be performed at a single centre: Queen Elizabeth University Hospital, Glasgow.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Informed written consent
- Suspected pleural malignancy requiring investigation by local anaesthetic thoracoscopy
Exclusion Criteria:
- Any contra-indication to local anaesthetic thoracoscopy
- Predicted pleural aspiration volume < 1 litre, as defined by a maximum pleural fluid depth of < 4 cm on thoracic ultrasound pre-aspiration
- Known contra-indication to MRI
- Previous attempt at talc pleurodesis
- Pregnancy
- • Renal impairment (eGFR ≤ 30 ml/min)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pleural Effusion
Malignant pleural effusion patients requiring investigation with thoracoscopy.
|
Measurement of intra-pleural pressure and the removal of pleural fluid.
Subject lies a long tunnel shaped scanner and images are recorded.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pleural Elastance
Time Frame: Single visit per subject
|
Pleural elastance (change in pleural pressure divided by change in pleural volume), where trapped lung will be predicted by pleural elastance ≥ 14.5 cm pleural pressure.
|
Single visit per subject
|
|
Clinical judgement
Time Frame: Single visit per subject
|
The clinical judgment of the Thoracoscopist as to the presence or absence of Trapped Lung
|
Single visit per subject
|
|
Trapped Lung
Time Frame: Single visit per subject
|
Occurrence of trapped lung, defined as incomplete lung re-expansion on the pre-discharge chest radiograph after local anaesthetic thoracoscopy
|
Single visit per subject
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PEL-VOUT Agreement
Time Frame: Single visit per subject
|
level of agreement between Indirect Pleural Elastance (PEL) computed using pleural fluid output (VOUT) and Direct PEL, computing using directly measured pleural cavity volume by MRI.
|
Single visit per subject
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GN16ON124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusion, Malignant
-
Sheng HuWuhan Binhui Biotechnology Co., Ltd.RecruitingMalignant Pleural Effusion | Malignant Peritoneal EffusionChina
-
Huazhong University of Science and TechnologyUnknownMalignant Ascites | Malignant Pleural Effusion,China
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
JemincareRecruitingMalignant Pleural Effusions (Mpe)China
-
Johns Hopkins UniversityEnrolling by invitationMalignant Pleural EffusionsUnited States
-
Singapore General HospitalCompletedMalignant Pleural EffusionsSingapore
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Eastern Regional Medical CenterRecruitingLoculated or Non-draining Malignant Pleural EffusionsUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingMalignant Pleural Effusions (Mpe)Spain
-
Assiut UniversityNot yet recruitingMalignant Pleural Effusions (Mpe)Egypt
Clinical Trials on Digital Pleural Manometry
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingMalignant Pleural Effusions (Mpe)Spain
-
Ankara City Hospital BilkentCompleted
-
University of OxfordTerminatedPleural EffusionUnited Kingdom
-
Nova Scotia Health AuthorityCompletedPneumothorax | AtelectasisCanada
-
Aly Sherif HassaballaCompleted
-
University of LouisvilleWithdrawnChest Pain | Dysphagia | GERD | Achalasia | Post FundoplicationUnited States
-
Hospices Civils de LyonCompleted
-
Medical University of WarsawNalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy...CompletedPleural Effusion | Exudative PleuritisPoland
-
China-Japan Friendship HospitalNot yet recruitingPleural Effusion Disorder
-
Wuhan YZY Biopharma Co., Ltd.RecruitingA Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLCNSCLC Stage IV | Malignant Pleural EffusionsChina